Pulmonary function testing: Tips on how to interpret the results

Journal of Respiratory Diseases

Volumn 20, Issue 12, 1999, Pages 809-822

  Salzman, Steve H ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ASTHMA; DISEASE SEVERITY; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG EMBOLISM; LUNG FUNCTION TEST; LUNG VOLUME; NORMAL VALUE; OBESITY; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; REVIEW; SPIROMETRY; UPPER RESPIRATORY TRACT OBSTRUCTION; VASCULITIS; VITAL CAPACITY;

EID: 0032776953     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Crapo RO, Hankinson JL, Irvin C, et al. American Thoracic Society Statement. Standardization of Spirometry. 1994 Update. Am J Respir Crit Care Med. 1995;152:1107-1136.
2. Becklake M, Crapo RO, Buist S, et al. American Thoracic Society Statement. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis. 1991;144:1202-1218.
3. Clausen JL. Prediction of normal values. In: Clausen JL, ed. Pulmonary Function Testing Guidelines and Controversies: Equipment, Methods, and Normal Values: California Thoracic Society. Orlando, Fla: Grune & Stratton Inc; 1982.
4. 1-FVC ratio. Mt Sinai J Med. 1990;57:85-92.
5. Gilbert R, Auchincloss JH. What is a 'restrictive' defect? Arch Intern Med. 1986;146: 1779-1781.
6. Quanjer PH, Tammeling GJ, Cotes JE, et al. Official Statement of the European Respiratory Society: lung volumes and forced ventilatory flows: report working party, standardization of lung function tests, European community for steel and coal. Eur Respir J. 1993; 6(suppl 16):5-40.
7. Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation. Philadelphia; Lea & Febiger: 1994.
8. Klein JS, Gamsu G, Webb WR, et al. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology. 1992;182:817-821.
9. Cotton DJ, Soparkar GR, Graham BL, Diffusing capacity in the clinical assessment of chronic airflow limitation. Med Clin North Am. 1996;80:549-564.
10. Crapo RO, Hankinson JL, Irvin C, et al. American Thoracic Society Statement. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique - 1995 update. Am J Respir Crit Care Med. 1995;152:2185-2198.
11. Kanengiser LC, Rapoport DM, Epstein H, Goldring RM, Volume adjustment of mechanics and diffusion in interstitial lung disease: lack of clinical relevance. Chest. 1989;96: 1036-1042.
12. Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983;128:501-506.
13. Rubinstein I, Zamel N, DuBarry L, Hoffstein V. Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med. 1990;112: 828-832.
14. Miller RD, Hyatt RE. Evaluation of obstructing lesions of the trachea and larynx by flow-volume loops. Am Rev Respir Dis. 1973; 108:475-481.
15. Newman KB, Mason UG III, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. 1995;152: 1382-1386.
16. Bolliger CT, Sopko J, Maurer P, Soler M, et al. The flow-volume loop in bilateral vocal cord paralysis. Chest 1993;104:1302-1304.
17. Sanders MH, Stiller RA. Still going around the flow-volume loop (editorial). Chest. 1992; 101:301-302.
18. Miller MR, Pincock AC, Oates GD, et al. Upper airway obstruction due to goitre: detection, prevalence and results of surgical management. Q J Med. 1990;74:177-188.
19. Bright P, Miller MR, Franklyn JA, Sheppard MC. The use of a neural network to detect upper airway obstruction caused by goiter. Am J Respir Crit Care Med. 1998;157:1885-1891.